RHCG is a 100% Australian-owned company and part of Australia’s most successful privately owned group in the healthcare/Research & Development sector.

High compound investment and growth over many years has been built on a strong foundation of innovation, expertise and a skilled workforce, combined with strong collaborative partnerships with recognised world-leaders in development and marketing of a wide range of leading edge medical technologies.

Research & Development outcomes have been strong, with significant product groups being developed for large multi-national companies including Johnson & Johnson & 3M.

The clean-air technology developed by Aeris Environmental Limited now has global reach.

Novapharm Research (Australia) Pty Ltd developed Ioscan - the world's first single unit-dose oral CT contrast media.

Nanosonics Limited launched a new High Level Disinfection/sterilisation technology platform during 2009.